750 related articles for article (PubMed ID: 34477077)
1. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
2. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
3. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
5. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
6. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.
Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T
Front Immunol; 2021; 12():771766. PubMed ID: 34899722
[TBL] [Abstract][Full Text] [Related]
7. Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement.
Quattri E; Zussino M; Lauro W; Berti E; Marzano AV; Genovese G
Front Med (Lausanne); 2022; 9():1000954. PubMed ID: 36186772
[TBL] [Abstract][Full Text] [Related]
8. Anti-BP180-type mucous membrane pemphigoid: report of two cases.
Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y
Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
10. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
11. Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid.
Hsu R; Lazarova Z; Yee C; Yancey KB
J Invest Dermatol; 1997 Oct; 109(4):557-61. PubMed ID: 9326390
[TBL] [Abstract][Full Text] [Related]
12. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
13. Mucous membrane pemphigoid.
Du G; Patzelt S; van Beek N; Schmidt E
Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762
[TBL] [Abstract][Full Text] [Related]
14. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
15. A Case of IgG and IgA Anti-Laminin-332 Antibody-Positive Mucous Membrane Pemphigoid with IgG and IgA Anti-Envoplakin and Anti-Periplakin Antibodies.
Matsushima Y; Kitano M; Hayashi D; Goto H; Mine M; Yokoe T; Kondo M; Habe K; Toiyama Y; Hashimoto T; Tsuruta D; Takeuchi K; Yamanaka K
Dermatopathology (Basel); 2022 Aug; 9(3):287-291. PubMed ID: 35997351
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
18. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.
Bekou V; Thoma-Uszynski S; Wendler O; Uter W; Schwietzke S; Hunziker T; Zouboulis CC; Schuler G; Sorokin L; Hertl M
J Invest Dermatol; 2005 Apr; 124(4):732-40. PubMed ID: 15816831
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
20. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]